A study published in the journal Cancer Epidemiology, Biomarkers and Prevention discusses the use of metobolomic analysis to screen pancreatic cancer patients and their prognosis.
Dr Masaru Yoshida, associate professor and chief of the division of metabolomics research at Kobe University Graduate School of Medicine in Kobe, Japan, states, "Although surgical resection can be a curative treatment for pancreatic cancer, more than 80 per cent of patients with pancreatic cancer have a locally advanced or metastatic tumour that is unresectable at the time of detection. Conventional examinations using blood, imaging and endoscopy are not appropriate for pancreatic cancer screening and early detection, so a novel screening and diagnostic method for pancreatic cancer is urgently required."
Researchers measured the levels of metabolites in patients' blood and healthy patients. They found 18 metabolites were different in cancer patients than healthy patients.
For the full article, visit http://www.aalatimes.com/2013/03/30/new-metabolite-based-diagnostic-test-could-help-detect-pancreatic-cancer-early/.
Dr Masaru Yoshida, associate professor and chief of the division of metabolomics research at Kobe University Graduate School of Medicine in Kobe, Japan, states, "Although surgical resection can be a curative treatment for pancreatic cancer, more than 80 per cent of patients with pancreatic cancer have a locally advanced or metastatic tumour that is unresectable at the time of detection. Conventional examinations using blood, imaging and endoscopy are not appropriate for pancreatic cancer screening and early detection, so a novel screening and diagnostic method for pancreatic cancer is urgently required."
Researchers measured the levels of metabolites in patients' blood and healthy patients. They found 18 metabolites were different in cancer patients than healthy patients.
For the full article, visit http://www.aalatimes.com/2013/03/30/new-metabolite-based-diagnostic-test-could-help-detect-pancreatic-cancer-early/.
No comments:
Post a Comment